Multiresidue analysis and probabilistic dietary risk assessment of 241 pesticides in wheatgrass (Triticum sp.) using LC-MS/MS in combination with QuEChERS extraction.

Wheatgrass is consumed as an important nutritious herbal food supplement across the globe; however, limited studies have been reported analyzing multiclass pesticides in this complex, nutrient-rich natural product. An analytical method was developed for the estimation of 241 pesticides in random wheatgrass samples collected from Delhi Northern Capital Region (Delhi-NCR). Extraction was performed by QuEChERS, cleaning was performed by dispersive solid-phase extraction and the extracts were analyzed using triple quadrupole liquid chromatography mass spectrometry. The limit of quantification was 0.5 µg/kg, which is well below the European Union Maximum Residue Level. The coefficient of determination was >0.991 across a calibration range of 0.5-100 µg/kg. The relative standard deviation values for 231 pesticides based on 10 replicates of samples spiked at 10 µg/kg were <5%. Among random samples, 54% confirmed the presence of at least one pesticide. The results indicated the presence of eight different pesticides among 38% of the total population with metribuzin at 299.7 µg/kg and carfentrazone-ethyl at 19.47 µg/kg exceeding the permissible limits among 6% of the total estimated population. The chronic and acute risk quotients as calculated were <1, indicating nonsignificant dietary risk to consumers. However, the presence of pesticides above the permissible limit is likely to result in adverse health effects to the consumers of herbal supplements from an urban population and incorporating measures would be useful to ensure the quality and safety of wheatgrass consumption.

Memory enhancement by Tamoxifen on amyloidosis mouse model.

Tamoxifen (TMX) is a selective estrogen receptor modulator (SERM) used in the treatment of breast cancer. Earlier studies show its neuroprotection via regulating apoptosis, microglial functions, and synaptic plasticity. TMX also showed memory enhancement in ovariectomized mice, and protection from amyloid induced damage in hippocampal cell line. These reports encouraged us to explore the role of TMX in relevance to Alzheimer's disease (AD). We report here, the effect of TMX treatment a) on memory, and b) levels of neurotransmitters (acetylcholine (ACh) and dopamine (DA)) in breeding-retired-female mice injected with beta amyloid1-42 (Aß1-42). Mice were treated with TMX (10mg/kg, i.p.) for 15 days. In Morris water maze test, the TMX treated mice escape latency decreased during training trials. They also spent longer time in the platform quadrant on probe trial, compared to controls. In Passive avoidance test, TMX treated mice avoided stepping on the shock chamber. This suggests that TMX protects memory from Aß induced toxicity. In frontal cortex, ACh was moderately increased, with TMX treatment. In striatum, dopamine was significantly increased, 3,4-dihydroxyphenylacetic acid (DOPAC) level and DOPAC/DA ratio was decreased post TMX treatment. Therefore, TMX enhances spatial and contextual memory by reducing dopamine metabolism and increasing ACh level in Aß1-42 injected-breeding-retired-female mice.

Rapid On-site Evaluation (ROSE) Cytology of Mucoepidermoid Carcinoma and its Diagnostic Pitfalls: a Case Report.

Fine needle aspiration cytology (FNAC) is a basic tool used for the preoperative diagnosis of superficial parotid swellings. Mucoepidermoid carcinoma accounts for approx. 5-10% of all salivary gland tumors. However, due to its morphologic heterogenicity, this tumor poses diagnostic difficulties in its interpretation. This is a case of a 45-year-old male with a history of recurrent swelling in the left infra-auricular region. Cytology with rapid on-site evaluation revealed a triphasic population of basaloid cells, squamoid cells, and intermediate cells on a mucoid background and reported as low-grade mucoepidermoid carcinoma in recurrence. The presence of a triphasic cellular component (mucous, intermediate, and squamoid cells) may not be seen in all cases of mucoepidermoid carcinoma (MEC) for definitive diagnosis. Clinico-radiological correlation, rapid on-site evaluation (ROSE), and high index of suspicion related to cystic lesions are important for early diagnosis and prompt treatment.

Biomarkers in Acute Traumatic Brain Injury: A Systematic Review and Meta-Analysis.

Traumatic brain injury (TBI) stands as a significant contributor to traumatic death and disability worldwide. In recent years, researchers have identified biomarkers to gauge useful outcomes in TBI patients. However, the enigma of timely sample collection to measure the biomarkers remains a controversial point in the case of TBI, unlike other degenerative diseases like Alzheimer's disease and Parkinson's disease, where we can collect the sample at any point in time. The purpose of this study is to evaluate the sensitivity of biomarkers in TBI concerning time of injury by analyzing recent available data on biomarkers in the medical literature. A total of 2,256 studies were initially retrieved from the search engine. After an initial screening, only 1,750 unique articles remained. After excluding review articles, animal studies, meta-analysis, and studies with children (screened by title and abstract), 30 kinds of literature were found relevant to search the required variables. Further 16 studies were excluded due to the nonavailability of complete variables or data. Finally, 14 studies remained and were included in the analysis. This study has analyzed the four most commonly described biomarkers for TBI in the literature: glial fibrillary acidic protein (GFAP), S100 calcium-binding protein B, ubiquitin carboxy-terminal hydrolase L1, and Tau. According to this statistical analysis, all biomarkers included in the study have shown their serum levels after trauma. So, all these biomarkers can be used for further study in the outcome prediction and diagnosis of TBI patients. The meta-analysis suggests that the best biomarker for TBI is Tau in cases where sample collection is done within 24 hours, while GFAP is the best biomarker to be studied for TBI if sample collection is done 24 hours after trauma.

Tubercular skull base osteomyelitis - A case report.

Skull base osteomyelitis (SBO) is a complex and fatal clinical entity caused by infections in the structures surrounding the skull base. It is mainly seen in immune compromised individuals. We report one such rare case of an atypical skull base osteomyelitis in a young, immune-competent female child of 12 years of age, who presented in the ER with misleading symptoms of stroke and was diagnosed incidentally to have SBO on imaging. Adding to the uniqueness of the case is the causative organism, which was identified as Mycobacterium Tuberculosis, an unusual cause of SBO.